Ali Vaziri-Gohar Selected Research

Ali Vaziri-Gohar Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 01/2019
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 11/2021
3	Adenocarcinoma 01/2023 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2016
1	Hyperglycemia 01/2023
1	Melanoma (Melanoma, Malignant) 09/2022
1	Cholangiocarcinoma 02/2022
1	Starvation 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 12/2022 - 01/2019
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2022 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 09/2022
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2022
2	NADP (NADPH)IBA 09/2022 - 01/2022
2	ivosidenibIBA 02/2022 - 01/2022
2	Tamoxifen FDA LinkGeneric 01/2017 - 02/2016
2	Estrogen ReceptorsIBA 01/2017 - 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Glutamate-Cysteine LigaseIBA 01/2023
1	Antidepressive Agents (Antidepressants)IBA 12/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2022
1	epacadostatIBA 12/2022
1	Tryptophan (L-Tryptophan)FDA Link 12/2022
1	KynurenineIBA 12/2022
1	Escitalopram FDA Link 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022
1	seribantumabIBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	AntibodiesIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Free RadicalsIBA 01/2022
1	MagnesiumIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Orphan Nuclear ReceptorsIBA 11/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2021
1	Gemcitabine FDA Link 11/2021
1	IsoenzymesIBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2017
1	Estrogen Receptor alphaIBA 01/2017
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 02/2016
1	Insulin-Like Growth Factor Binding Protein 1IBA 02/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2016
1	Selective Estrogen Receptor Modulators (SERM)IBA 02/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
5	Therapeutics 09/2022 - 02/2016
1	Immunotherapy 09/2022